Beta-Blocker Dose Equivalence: Labetalol to Metoprolol Tartrate
A dose of 200 mg of labetalol twice daily is approximately equivalent to 75 mg of metoprolol tartrate twice daily.
Dose Equivalence Rationale
According to the ACC/AHA guidelines, labetalol and metoprolol have different pharmacological profiles that affect their dosing equivalence 1:
- Metoprolol tartrate is a selective beta-1 blocker with a recommended dose range of 100-200 mg twice daily for cardiovascular conditions 1
- Labetalol is a combined alpha- and beta-receptor blocker with a recommended dose range of 200-800 mg twice daily 1
The dose equivalence can be determined by examining their relative potencies and target doses:
Comparative Analysis
Pharmacological differences:
Target doses in guidelines:
Clinical comparison studies:
Clinical Considerations
When converting between these medications, consider these important factors:
- Hemodynamic effects: Labetalol causes less reduction in heart rate than metoprolol at equivalent antihypertensive doses due to its alpha-blocking properties 3
- Side effect profiles:
Dosing Algorithm
For converting from metoprolol tartrate 75 mg BID to labetalol:
- Initial labetalol dose: 200 mg twice daily
- Monitor blood pressure and heart rate response
- Titrate by 100 mg twice daily every 2-3 days as needed
- Maximum dose: 600 mg twice daily 1
For converting from labetalol to metoprolol tartrate:
- For every 200 mg of labetalol, use approximately 75 mg of metoprolol tartrate
- Start at the lower end of the equivalent dose range
- Titrate based on blood pressure and heart rate response
Important Caveats
- Individual variability: Patient response may vary significantly based on comorbidities, age, and concurrent medications
- Gradual transition: When switching between these medications, consider a gradual transition to avoid rebound effects
- Monitoring: Close monitoring of blood pressure and heart rate is essential during conversion
- Heart failure patients: In patients with heart failure, metoprolol succinate (extended-release) is preferred over metoprolol tartrate due to more consistent beta-blockade 5
Remember that labetalol's combined alpha- and beta-blocking properties make it particularly useful in situations where peripheral vasodilation is beneficial, while metoprolol's cardioselectivity may be advantageous in patients with reactive airway disease.